N,N,N-Trimethyloctan-1-aminium chloride
Based on 1 Customer Validation
N,N,N-Trimethyloctan-1-aminium chloride is a quaternary ammonium salt consisting of a positively charged N,N,N-trimethyloctan-1-aminium cation and a negatively charged chloride anion. The compound is commonly used as a surfactant and emulsifier in a variety of applications including detergents, fabric softeners and personal care products. It can also be used as a phase transfer catalyst in organic chemical reactions, facilitating the transfer of reactants between immiscible phases. Additionally, it has antimicrobial properties and is used as a disinfectant or antiseptic in some products.
For research use only. We do not sell to patients.
- Purity : 99.0%
- CAS No.: 10108-86-8
- Formula: C11H26ClN
- Molecular Weight:207.79
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Biological Activity
Description
In Vitro
N,N,N-Trimethyloctan-1-aminium chloride is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 10108-86-8
-
Appearance Solid
-
Molecular Weight 207.79
-
Formula C11H26ClN
-
Color White to off-white
-
SMILES
CCCCCCCC[N+](C)(C)C.[Cl-]
-
Synonyms
Trimethyl-n-octylammonium Chloride
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
Purity & Documentation
-
Data Sheet (236 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)